PFE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).
Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.
Pfizer's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.
For the Drug Manufacturers - General subindustry, Pfizer's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Pfizer's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:
* The bar in red indicates where Pfizer's Margin of Safety % (DCF Dividends Based) falls into.
Thank you for viewing the detailed overview of Pfizer's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.
Jennifer B. Damico | officer: SVP & Controller | C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017 |
Ronald E Blaylock | director | |
Scott Gottlieb | director | MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142 |
Christoffel Boshoff | officer: Executive Vice President | 66 HUDSON BOULEVARD EAST, NEW YORK NY 10001-2192 |
Payal Sahni | officer: Executive Vice President | ATTN: PFIZER CORP. SECRETARY, 235 EAST 42ND ST., NEW YORK NY 10017 |
Carapezzi William R Jr | officer: Executive Vice President | 600 MOUNTAIN AVENUE, MURRAY HILL NJ 07921 |
Douglas M Lankler | officer: Senior Vice President | PFIZER INC. ATTN: CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017 |
Mikael Dolsten | officer: Senior Vice President | 5 GIRALDA FARMS, MADISON NJ 07940 |
David M Denton | officer: Chief Financial Officer & EVP | 1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117 |
William Pao | officer: Executive Vice President | C/O CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017 |
Michael Mcdermott | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, 235 EAST 42ND STREET NY 10017 |
Rady A Johnson | officer: Executive Vice President | PFIZER INC. ATTN CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017 |
Alexander R Mackenzie | officer: Executive Vice President | C/O PFIZER CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017 |
Sally Susman | officer: Senior Vice President | 767 FIFTH AVE, EOTIC LAWDER CORP, NEW YORK NY 10153 |
Angela Hwang | officer: Group President | 235 EAST 42ND STREET, ATTN: CORPORATE SECRETARY, NEW YORK NY 10017 |
From GuruFocus
By GuruFocus News • 02-10-2025
By GuruFocus News • 02-12-2025
By Business Wire • 01-28-2025
By GuruFocus News • 02-28-2025
By Business Wire • 02-12-2025
By Khac Phu Nguyen • 02-03-2025
By Marketwired • 03-05-2025
By GuruFocus News • 02-03-2025
By GuruFocus News • 02-13-2025
By GuruFocus News • 02-04-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.